For my first Drug Channels news roundup of 2021, I focus on two remarkable, must-read reports that provide extraordinary details about the hidden economics of our drug channel:
- The Center for Medicare & Medicaid Services’ new transparency rule discloses how much major insurers overpay hospitals for outpatient drugs.
- A new Senate report reveals unprecedented information about PBMs, manufacturers, and the gross-to-net bubble for insulin.
Plus, a 2021 update to my all-time favorite chart.
P.S. Join the nearly 11,000 followers of my daily links to neat stuff at @DrugChannels on Twitter. You can also join my nearly 15,000 followers on LinkedIn.
Read more »
Source: Post feed
